These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 23319291)
1. Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia. Ryan EL; Lynch ME; Taddeo E; Gleason TJ; Epstein MP; Fridovich-Keil JL J Inherit Metab Dis; 2013 Nov; 36(6):1049-61. PubMed ID: 23319291 [TBL] [Abstract][Full Text] [Related]
2. The ability of an LC-MS/MS-based erythrocyte GALT enzyme assay to predict the phenotype in subjects with GALT deficiency. Demirbas D; Huang X; Daesety V; Feenstra S; Haskovic M; Qi W; Gubbels CS; Hecht L; Levy HL; Waisbren SE; Berry GT Mol Genet Metab; 2019 Apr; 126(4):368-376. PubMed ID: 30718057 [TBL] [Abstract][Full Text] [Related]
3. Modifiers of ovarian function in girls and women with classic galactosemia. Spencer JB; Badik JR; Ryan EL; Gleason TJ; Broadaway KA; Epstein MP; Fridovich-Keil JL J Clin Endocrinol Metab; 2013 Jul; 98(7):E1257-65. PubMed ID: 23690308 [TBL] [Abstract][Full Text] [Related]
6. Galactosemia: when is it a newborn screening emergency? Berry GT Mol Genet Metab; 2012 May; 106(1):7-11. PubMed ID: 22483615 [TBL] [Abstract][Full Text] [Related]
7. Effect of genotype on galactose-1-phosphate in classic galactosemia patients. Yuzyuk T; Balakrishnan B; Schwarz EL; De Biase I; Hobert J; Longo N; Mao R; Lai K; Pasquali M Mol Genet Metab; 2018 Nov; 125(3):258-265. PubMed ID: 30172461 [TBL] [Abstract][Full Text] [Related]
8. A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolism. Rasmussen SA; Daenzer JMI; MacWilliams JA; Head ST; Williams MB; Geurts AM; Schroeder JP; Weinshenker D; Fridovich-Keil JL J Inherit Metab Dis; 2020 May; 43(3):518-528. PubMed ID: 31845342 [TBL] [Abstract][Full Text] [Related]
9. A multinational study of acute and long-term outcomes of Type 1 galactosemia patients who carry the S135L (c.404C > T) variant of GALT. Katler QS; Stepien KM; Paull N; Patel S; Adams M; Balci MC; Berry GT; Bosch AM; DeLaO A; Demirbas D; Edman J; Ficicioglu C; Goff M; Hacker S; Knerr I; Lancaster K; Li H; Mendelsohn BA; Nichols B; de Rezende Pinto WBV; Rocha JC; Rubio-Gozalbo ME; Saad-Naguib M; Scholl-Buergi S; Searcy S; de Souza PVS; Wittenauer A; Fridovich-Keil JL J Inherit Metab Dis; 2022 Nov; 45(6):1106-1117. PubMed ID: 36093991 [TBL] [Abstract][Full Text] [Related]
10. N- and O-linked glycosylation of total plasma glycoproteins in galactosemia. Liu Y; Xia B; Gleason TJ; Castañeda U; He M; Berry GT; Fridovich-Keil JL Mol Genet Metab; 2012 Aug; 106(4):442-54. PubMed ID: 22743281 [TBL] [Abstract][Full Text] [Related]
11. Biochemical changes and clinical outcomes in 34 patients with classic galactosemia. Yuzyuk T; Viau K; Andrews A; Pasquali M; Longo N J Inherit Metab Dis; 2018 Mar; 41(2):197-208. PubMed ID: 29350350 [TBL] [Abstract][Full Text] [Related]
12. The molecular relationship between deficient UDP-galactose uridyl transferase (GALT) and ceramide galactosyltransferase (CGT) enzyme function: a possible cause for poor long-term prognosis in classic galactosemia. Lebea PJ; Pretorius PJ Med Hypotheses; 2005; 65(6):1051-7. PubMed ID: 16125333 [TBL] [Abstract][Full Text] [Related]
13. A yeast expression system for human galactose-1-phosphate uridylyltransferase. Fridovich-Keil JL; Jinks-Robertson S Proc Natl Acad Sci U S A; 1993 Jan; 90(2):398-402. PubMed ID: 8421669 [TBL] [Abstract][Full Text] [Related]
14. Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase. Riehman K; Crews C; Fridovich-Keil JL J Biol Chem; 2001 Apr; 276(14):10634-40. PubMed ID: 11152465 [TBL] [Abstract][Full Text] [Related]
15. The molecular biology of galactosemia. Elsas LJ; Lai K Genet Med; 1998; 1(1):40-8. PubMed ID: 11261429 [TBL] [Abstract][Full Text] [Related]
16. A Drosophila melanogaster model of classic galactosemia. Kushner RF; Ryan EL; Sefton JM; Sanders RD; Lucioni PJ; Moberg KH; Fridovich-Keil JL Dis Model Mech; 2010; 3(9-10):618-27. PubMed ID: 20519569 [TBL] [Abstract][Full Text] [Related]
17. Neonatal GALT gene replacement offers metabolic and phenotypic correction through early adulthood in a rat model of classic galactosemia. Daenzer JMI; Rasmussen SA; Patel S; McKenna J; Fridovich-Keil JL J Inherit Metab Dis; 2022 Mar; 45(2):203-214. PubMed ID: 34964137 [TBL] [Abstract][Full Text] [Related]
18. [From gene to disease; galactosemia and galactose-1-phosphate uridyltransferase deficiency]. Bosch AM; Waterham HR; Bakker HD Ned Tijdschr Geneeskd; 2004 Jan; 148(2):80-1. PubMed ID: 14753129 [TBL] [Abstract][Full Text] [Related]
19. A novel splicing mutation in GALT gene causing Galactosemia in Ecuadorian family. De Lucca M; Barba C; Casique L Clin Chim Acta; 2017 Jul; 470():20-23. PubMed ID: 28450132 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous occurrence of various mutations and polymorphisms in cis and in trans of the galactose-1-phosphate uridyltransferase gene in a Turkish family with classical galactosemia. Schuster V; Podskarbi T; Ottensmeier H; Haubner M; Shin YS J Mol Med (Berl); 1998 Sep; 76(10):715-9. PubMed ID: 9766850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]